These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30472652)

  • 1. Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.
    Nayar S; Campos J; Smith CG; Iannizzotto V; Gardner DH; Colafrancesco S; Pipi E; Kollert F; Hunter KJ; Brewer C; Buckley CD; Bowman SJ; Priori R; Valesini G; Juarez M; Fahy WA; Fisher BA; Payne A; Allen RA; Barone F
    Ann Rheum Dis; 2019 Feb; 78(2):249-260. PubMed ID: 30472652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome.
    Juarez M; Diaz N; Johnston GI; Nayar S; Payne A; Helmer E; Cain D; Williams P; Devauchelle-Pensec V; Fisher BA; Giacomelli R; Gottenberg JE; Guggino G; Kvarnström M; Mariette X; Ng WF; Rosas J; Sánchez Bursón J; Triolo G; Barone F; Bowman SJ
    Rheumatology (Oxford); 2021 Mar; 60(3):1364-1375. PubMed ID: 32949140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PI3Kδ inhibitor parsaclisib ameliorates pathology and reduces autoantibody formation in preclinical models of systemic lupus erythematosus and Sjӧgren's syndrome.
    Scuron MD; Fay BL; Connell AJ; Oliver J; Smith PA
    Int Immunopharmacol; 2021 Sep; 98():107904. PubMed ID: 34214886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
    Lisi S; Sisto M; D'Amore M; Lofrumento DD
    Int Immunol; 2015 Apr; 27(4):183-94. PubMed ID: 25381666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
    Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
    Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cenerimod, a selective S1P
    Gerossier E; Nayar S; Froidevaux S; Smith CG; Runser C; Iannizzotto V; Vezzali E; Pierlot G; Mentzel U; Murphy MJ; Martinic MM; Barone F
    Arthritis Res Ther; 2021 Nov; 23(1):289. PubMed ID: 34839819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alleviating effect of paeoniflorin-6'-O-benzene sulfonate in antigen-induced experimental Sjögren's syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
    Chen X; Zhang P; Liu Q; Zhang Q; Gu F; Xu S; Körner H; Wu H; Wei W
    Int Immunopharmacol; 2020 Mar; 80():106199. PubMed ID: 31955068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren's syndrome: from pathogenesis to novel therapeutic targets.
    Barone F; Colafrancesco S
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):58-62. PubMed ID: 27586806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
    Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
    Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
    Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
    Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
    Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
    Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
    Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation.
    Rivière E; Pascaud J; Tchitchek N; Boudaoud S; Paoletti A; Ly B; Dupré A; Chen H; Thai A; Allaire N; Jagla B; Mingueneau M; Nocturne G; Mariette X
    Ann Rheum Dis; 2020 Nov; 79(11):1468-1477. PubMed ID: 32843324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
    Puñet-Ortiz J; Sáez Moya M; Cuenca M; Caleiras E; Lazaro A; Engel P
    Front Immunol; 2018; 9():2661. PubMed ID: 30519241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
    Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
    Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.
    Chen S; Paveley R; Kraal L; Sritharan L; Stevens E; Dedi N; Shock A; Shaw S; Juarez M; Yeremenko N; Baeten D; Payne A
    J Autoimmun; 2020 Jul; 111():102435. PubMed ID: 32360069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome.
    Bombardieri M; Barone F; Humby F; Kelly S; McGurk M; Morgan P; Challacombe S; De Vita S; Valesini G; Spencer J; Pitzalis C
    J Immunol; 2007 Oct; 179(7):4929-38. PubMed ID: 17878393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren's syndrome.
    Szyszko EA; Aqrawi LA; Jonsson R; Brokstad KA; Skarstein K
    Autoimmunity; 2016; 49(1):41-9. PubMed ID: 26324998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Multiple Roles of B Cells in the Pathogenesis of Sjögren's Syndrome.
    Du W; Han M; Zhu X; Xiao F; Huang E; Che N; Tang X; Zou H; Jiang Q; Lu L
    Front Immunol; 2021; 12():684999. PubMed ID: 34168653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.